Ranveer Singh is roaring on the 5th Saturday with Dhurandhar 2's ticket sales taking very good jumps - day 31 BMS trends.

As a China leading Quick Lock waterproof connector factory, Jnicon Group has consistently pushed the boundaries of interconnect technology to meet these rigorous demands. Central to their portfolio is ...

ADAG stock outlook: single-asset bet on ADG126 masked anti-CTLA-4 cancer therapy, with AACR 2026 catalysts, partnerships, and ...

Trump’s deal with drugmakers was meant to see prices fall. But some companies have been raising them, Senate report says - ...

The company is hoping to seek accelerated approval in first-line HLA-A*A2:01-negative metastatic uveal melanoma based on data ...

Burton Theatre students drew quite a crowd this past weekend as they awed the audience with a dancing, singing, acting, and ...

LEBANON, N.H., April 15, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently ...

B&M customers are raving about a 'decorative' £10 furniture set that looks 'amazing' in their homes. Interior design ...

June Squibb at 96 still has sharp memories of Ethel Merman. Squibb appeared on the April 13 episode of Still Here Hollywood, ...

Servier $210 million bet on IDEAYA's uveal melanoma therapy darovasertib seems to have paid off, as the drug has hit the mark in a phase 2/3 that could form the basis of regulatory filings later this ...

Bristol Myers Squibb (BMS) has evolved its Standing in the Gaap programme by launching one of the largest multiple myeloma (MM) surveys ever conducted in the US. Designed to help identify the factors ...

A phase 2/3 trial of Ideaya Biosciences and Servier’s eye cancer candidate has hit its primary endpoint, teeing up a filing for accelerated FDA approval in the second half of th ...